Status:
RECRUITING
Transdiagnostic Metacognitive Therapy Compared to Disorder-Specific Cognitive-Behavioral Therapy for Anxiety Disorders
Lead Sponsor:
Benjamin Bohman
Collaborating Sponsors:
Karolinska Institutet
Region Stockholm
Conditions:
Generalized Anxiety Disorder (GAD)
Social Anxiety Disorder (SAD)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background Anxiety disorders are the most prevalent psychiatric disorders around the world. Effective treatment consists of pharmacotherapy or psychological treatment based on cognitive-behavioral t...
Eligibility Criteria
Inclusion
- 18 years of age or older
- A principal (most interfering and/or severe) diagnosis of GAD, SAD or PTSD
- If on pharmacological treatment, no change in dose during the last six weeks
- Ability to read and speak Swedish
Exclusion
- A current diagnosis of psychotic disorder, bipolar disorder, neurocognitive disorder, or moderate to severe substance use disorder
- Acute risk of suicide
- Simultaneous psychological treatment
Key Trial Info
Start Date :
August 27 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT06937892
Start Date
August 27 2025
End Date
December 1 2028
Last Update
December 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stockholm North Psychiatry Clinic
Stockholm, Sweden